Ubs Group Ag Standard Biotools Inc. Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Standard Biotools Inc. stock. As of the latest transaction made, Ubs Group Ag holds 406,988 shares of LAB stock, worth $435,477. This represents 0.0% of its overall portfolio holdings.

Number of Shares

406,988

Previous 403,153 0.95%

Holding current value

$435,477

Previous $705,000 37.73%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$1.01 - $2.06 $3,873 - $7,900	3,835 Added 0.95%	406,988 $439,000
Q4 2024 Feb 14, 2025	BUY	$1.5 - $2.26 $224,772 - $338,656	149,848 Added 59.16%	403,153 $705,000
Q3 2024 Nov 14, 2024	BUY	$1.42 - $2.35 $110,431 - $182,757	77,769 Added 44.3%	253,305 $488,000
Q2 2024 Aug 13, 2024	SELL	$1.65 - $2.92 $508,873 - $900,551	-308,408 Reduced 63.73%	175,536 $310,000
Q1 2024 May 13, 2024	BUY	$1.87 - $2.78 $865,290 - $1.29 Million	462,722 Added 2180.39%	483,944 $1.31 Million
Q4 2023 Feb 09, 2024	BUY	$1.59 - $2.73 $8,891 - $15,266	5,592 Added 35.78%	21,222 $46,000
Q3 2023 Nov 09, 2023	SELL	$1.9 - $3.05 $6,004 - $9,638	-3,160 Reduced 16.82%	15,630 $45,000
Q2 2023 Aug 11, 2023	BUY	$1.47 - $2.56 $1,646 - $2,867	1,120 Added 6.34%	18,790 $36,000
Q1 2023 May 12, 2023	SELL	$1.3 - $2.24 $19,241 - $33,154	-14,801 Reduced 45.58%	17,670 $34,000
Q4 2022 Feb 08, 2023	BUY	$0.93 - $1.52 $12,429 - $20,314	13,365 Added 69.95%	32,471 $37,000
Q3 2022 Nov 10, 2022	SELL	$1.1 - $2.06 $11,378 - $21,308	-10,344 Reduced 35.12%	19,106 $21,000
Q2 2022 Aug 10, 2022	SELL	$1.6 - $3.99 $1.05 Million - $2.62 Million	-657,596 Reduced 95.71%	29,450 $47,000
Q1 2022 May 16, 2022	SELL	$2.8 - $3.96 $106,733 - $150,951	-38,119 Reduced 5.26%	687,046 $2.47 Million
Q4 2021 Feb 14, 2022	SELL	$3.63 - $6.13 $228,679 - $386,171	-62,997 Reduced 7.99%	725,165 $2.84 Million
Q3 2021 Nov 15, 2021	SELL	$5.5 - $7.41 $38,329 - $51,640	-6,969 Reduced 0.88%	788,162 $5.19 Million
Q2 2021 Aug 13, 2021	SELL	$4.35 - $6.35 $1.01 Million - $1.48 Million	-233,067 Reduced 22.67%	795,131 $4.9 Million
Q1 2021 May 12, 2021	BUY	$3.94 - $7.09 $1.78 Million - $3.2 Million	451,502 Added 78.29%	1,028,198 $4.65 Million
Q4 2020 Feb 11, 2021	BUY	$5.45 - $8.65 $53,546 - $84,986	9,825 Added 1.73%	576,696 $3.46 Million
Q3 2020 Nov 12, 2020	SELL	$4.34 - $11.43 $1.68 Million - $4.42 Million	-386,543 Reduced 40.54%	566,871 $4.21 Million
Q2 2020 Jul 31, 2020	BUY	$1.85 - $5.29 $1.48 Million - $4.23 Million	800,372 Added 522.98%	953,414 $3.82 Million
Q1 2020 May 01, 2020	BUY	$1.24 - $4.35 $56,989 - $199,921	45,959 Added 42.92%	153,042 $389,000
Q4 2019 Feb 14, 2020	BUY	$2.3 - $5.12 $244,786 - $544,916	106,429 Added 16273.55%	107,083 $373,000
Q3 2019 Nov 14, 2019	SELL	$4.63 - $12.15 $10,412 - $27,325	-2,249 Reduced 77.47%	654 $3,000
Q2 2019 Aug 14, 2019	BUY	$11.49 - $14.17 $6,514 - $8,034	567 Added 24.27%	2,903 $36,000
Q1 2019 May 14, 2019	SELL	$8.47 - $14.36 $60,475 - $102,530	-7,140 Reduced 75.35%	2,336 $31,000
Q4 2018 Feb 14, 2019	BUY	$7.18 - $8.83 $25,007 - $30,754	3,483 Added 58.12%	9,476 $82,000
Q3 2018 Nov 14, 2018	BUY	$5.92 - $8.35 $15,078 - $21,267	2,547 Added 73.91%	5,993 $45,000
Q2 2018 Aug 14, 2018	BUY	$4.86 - $6.24 $16,465 - $21,141	3,388 Added 5841.38%	3,446 $21,000
Q1 2018 May 15, 2018	SELL	$5.75 - $7.97 $13,460 - $18,657	-2,341 Reduced 97.58%	58 $0
Q4 2017 Feb 14, 2018	SELL	$4.46 - $6.45 $6,797 - $9,829	-1,524 Reduced 38.85%	2,399 $14,000
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.49 $12,123 - $18,748	3,415 Added 672.24%	3,923 $19,000
Q2 2017 Aug 14, 2017	SELL	N/A	-770 Reduced 60.25%	508 $2,000
Q1 2017 Nov 14, 2017	BUY	N/A	1,278	1,278 $7,000

Others Institutions Holding LAB

# of Institutions

151

Shares Held

280M

Call Options Held

Put Options Held

36.6K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $84.2M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account